Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.060
-0.010 (-0.93%)
At close: Jul 25, 2025, 4:00 PM
1.080
+0.020 (1.88%)
After-hours: Jul 25, 2025, 7:28 PM EDT
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,738,041
Market Cap
205.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 7 days ago - Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides - GlobeNewsWire
- 8 days ago - Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility - GlobeNewsWire
- 9 days ago - Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch - GlobeNewsWire
- 11 days ago - Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs - GlobeNewsWire
- 15 days ago - Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation - GlobeNewsWire
- 25 days ago - Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters - GlobeNewsWire
- 5 weeks ago - Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery - GlobeNewsWire
- 6 weeks ago - Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives - GlobeNewsWire